Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer

NCT00091286 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Slow accruals

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine

Sponsor

Craig L Slingluff, Jr

Collaborators

[object Object]